Navigation Links
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
Date:11/1/2011

TUESDAY, Nov. 1 (HealthDay News) -- Age in itself should not be a factor in deciding whether blood cancer patients are candidates for stem cell transplantation, according to a new study.

Blood cancers include leukemia, lymphoma and myeloma.

For the study, researchers analyzed long-term outcomes among 372 blood cancer patients aged 60 to 75 who underwent a "mini-transplant," which is a "kinder, gentler" form of allogeneic (cells from another person) stem cell transplantation developed at the Fred Hutchinson Cancer Research Center in Seattle.

The five-year rates of overall survival and disease progression-free survival among the patients were 35 percent and 32 percent, respectively. Comparable survival rates were seen when the patients were divided into three age groups -- 60 to 64, 65 to 69, and 70 to 75 -- suggesting that age plays a limited role in the success of the mini-transplant.

While a survival rate of one-third may seem low, all of the patients would have died within months if they didn't have the transplant, Dr. Mohamed Sorror, an assistant member of the Hutchinson Center's Clinical Research Division, noted in a news release from the Center.

The investigators also found that greater cancer aggressiveness and having a larger number of medical problems not linked to cancer ("comorbidities") were two factors that affected survival, regardless of age.

For example, the five-year survival for patients with less aggressive cancer and fewer comorbidities was 69 percent, compared with 23 percent for patients with more aggressive cancer and a large number of comorbidities, according to the report in the Nov. 2 issue of the Journal of the American Medical Association.

Conventional stem cell transplants are generally not performed on blood cancer patients older than 60 because high doses of total-body radiation and potent chemotherapy are used to prepare patients for transplantation.

However, the mini-transplant relies on the donor's immune cells to kill the cancer, and low-dose radiation and chemotherapy is used to suppress the immune system rather than destroy it.

More information

The U.S. Centers for Disease Control and Prevention has more about blood cancers.

-- Robert Preidt

SOURCE: Fred Hutchinson Cancer Research Center, news release, Nov. 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dementia Rates Escalate as Brain Capacity Diminishes with Age
2. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
3. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
4. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
5. Rate Regulation for Health Insurance: Obama Administration Should Look to CAs Model Law Which Has Saved Drivers $62 Billion Since 1988
6. CareTech Solutions Showcases Web Portal for Hospital Boards and Administrators at HIMSS10
7. National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics
8. Adverse events rate is low when propofol is administered by trained professional
9. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
10. New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid
11. The Power of Prayer Deterred Tsunami's Destruction Ministry Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
(Date:9/25/2017)... ... September 25, 2017 , ... Dr. Edward Hebert is celebrating ... imagine doing anything else,” said Dr. Hebert. “I count my blessings daily for the ... with my patients is what I look forward to the most. The relationships I ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a tender and ... share with the others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, ... is much like the character in her book. She shares, “Mr. Rice is struggling ...
(Date:9/25/2017)... ... , ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the ... drinks, with the new NEXTY Gold Award at the Natural Products Expo East trade ... which is reserved for just those companies that hit high marks on the criteria ...
(Date:9/25/2017)... ... September 25, 2017 , ... Emerald Ash Borers kill Ash trees in as ... throughout the Philadelphia region. A video by Rob Nagy, ISA Certified Arborist at Giroud ... While several are dead or showing signs of decline from Emerald Ash Borers, two ...
(Date:9/24/2017)... ... ... Andrea Purcell, NMD, had an epiphany one evening. Four months pregnant, she sat sobbing at ... pregnancy was so hard. She wondered why no one talks about what it is really ... she decided to write what she wished her friends and colleagues could have told her: ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the ... has been granted Fast Track status by the US Food ... HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company will ... sequential therapy targeting patients who are admitted to Emergency Departments ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months after ... is pleased to announce the appointment of three new ... Wynne , Dominic Jones-Phillips and James ... Tammy Wynne ... of market access writers. She has over ten years, ...
(Date:8/31/2017)... , Aug. 31, 2017 PM360,s annual ... guide to the latest innovations happening across the industry. ... publication to focus on providing a comprehensive look at ... issue covers the most innovative companies, startups, divisions, products, ... "Everyone in this industry wants ...
Breaking Medicine Technology: